Literature DB >> 970996

Radiological cervical arthritis in populations.

J S Lawrence.   

Abstract

The prevalence of cervical rheumatoid arthritis and its relationship to rheumatoid serum factors and erosive arthritis in peripheral joints has been studied in radiographs of the cervical spine and of the hands and feet drawn from 12 population samples. The changes were graded in accordance with the Atlas of Standard Radiographs of Arthritis. Rheumatoid arthritis of the cervical spine (grades 2-4) was observed in 4.1% of males and 4.7% of females aged 15 and over. Prevalence was greatest in those born before 1900, 15% of whom were affected. There was a significant association with the sheep cell agglutination test but not with the bentonite flocculation test, though the latter correlated well with erosive arthritis in the joints of the hands and feet. Arthritis of the cervical spine showed a significant correlation with both seropositive and seronegative erosive arthritis in the peripheral joints. A significantly higher prevalence of cervical arthritis than expected was noted in two population samples, one in Germany and the other in West Africa, though in neither was there a high prevalence of peripheral arthritis. The German population had relatively high antistreptolysin titres. A low prevalence of cervical arthritis was noted in populations in Czechoslovakia and in Arizona. 'Congenital' block vertebra had a prevalence of 0.9% in persons born before 1935, but none was observed in those born since. The figures suggest that environmental influences predisposing to cervical arthritis and block vertebra have changed in the last 40 years.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 970996      PMCID: PMC1007398          DOI: 10.1136/ard.35.4.365

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  Epidemiology of the sheep cell agglutination test.

Authors:  J BALL; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1961-09       Impact factor: 19.103

2.  Prevalence of rheumatoid arthritis.

Authors:  J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1961-03       Impact factor: 19.103

3.  Rheumatoid arthritis of the cervical spine in the adult.

Authors:  J SHARP; D W PURSER; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1958-09       Impact factor: 19.103

4.  Differential diagnosis of ankylosing spondylitis.

Authors:  J SHARP
Journal:  Br Med J       Date:  1957-04-27

5.  Spondylitis in post-pubertal patients with rheumatoid arthritis of juvenile onset.

Authors:  M ZIFF; V CONTRERAS; C MCEWEN
Journal:  Ann Rheum Dis       Date:  1956-03       Impact factor: 19.103

6.  Rheumatic Complaints in a Rural Population.

Authors:  J M Bremner
Journal:  Ann Rheum Dis       Date:  1961-06       Impact factor: 19.103

7.  [Serologic and clinical experiences with antistreptolysin reaction in acute and chronic rheumatoid arthritis].

Authors:  F SCHEIFFARTH; F LEGLER
Journal:  Arztl Wochensch       Date:  1951-07-13

8.  [Longitudinal study on rheumatoid diseases in the rural population of Oberhörlen in Hessen. 1. Inflammatory rheumatoid diseases].

Authors:  T Behrend; J S Lawrence; H Behrend; R Koch
Journal:  Z Rheumaforsch       Date:  1972 Mar-Apr

9.  Still's disease in the adult.

Authors:  E G Bywaters
Journal:  Ann Rheum Dis       Date:  1971-03       Impact factor: 19.103

10.  Fluoridation and the rheumatic diseases. A comparison of rheumatism in Watford and Leigh.

Authors:  B M Ansell; J S Lawrence
Journal:  Ann Rheum Dis       Date:  1966-01       Impact factor: 19.103

View more
  2 in total

1.  A prospective study of the radiological changes in the cervical spine in early rheumatoid disease.

Authors:  J Winfield; D Cooke; A S Brook; M Corbett
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

2.  The surgical treatment of myelopathy secondary to rheumatoid arthritis of the lower cervical spine.

Authors:  O Kataoka; K Hirohata; A Kurihara
Journal:  Int Orthop       Date:  1979       Impact factor: 3.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.